{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:32:48Z","timestamp":1778171568177,"version":"3.51.4"},"reference-count":39,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":423,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1002\/pds.3678","type":"journal-article","created":{"date-parts":[[2014,7,5]],"date-time":"2014-07-05T05:35:06Z","timestamp":1404538506000},"page":"1205-1212","source":"Crossref","is-referenced-by-count":12,"title":["Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study"],"prefix":"10.1002","volume":"23","author":[{"given":"David J.","family":"Graham","sequence":"first","affiliation":[{"name":"Office of Surveillance and Epidemiology; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunthel","family":"By","sequence":"additional","affiliation":[{"name":"Office of Biostatistics; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"McKean","sequence":"additional","affiliation":[{"name":"Acumen LLC; Burlingame CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mosholder","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Kornegay","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"Racoosin","sequence":"additional","affiliation":[{"name":"Office of New Drugs; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Young","sequence":"additional","affiliation":[{"name":"Acumen LLC; Burlingame CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Levenson","sequence":"additional","affiliation":[{"name":"Office of Biostatistics; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"MaCurdy","sequence":"additional","affiliation":[{"name":"Acumen LLC; Burlingame CA USA"},{"name":"Stanford University; Stanford CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Worrall","sequence":"additional","affiliation":[{"name":"Centers for Medicare & Medicaid Services; Washington, DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Kelman","sequence":"additional","affiliation":[{"name":"Centers for Medicare & Medicaid Services; Washington, DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,5]]},"reference":[{"key":"10.1002\/pds.3678-BIB0001|pds3678-cit-0001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha 4 beta 2 and full agonist at alpha 7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1002\/pds.3678-BIB0002|pds3678-cit-0002","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1368-5031.2006.00955.x","article-title":"The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline","volume":"60","author":"Foulds","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1002\/pds.3678-BIB0003|pds3678-cit-0003","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMct0800146","article-title":"Varenicline for tobacco dependence","volume":"359","author":"Hays","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3678-BIB0004|pds3678-cit-0004","unstructured":"Product labeling for Chantix (varenicline) tablets http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021928s030lbl.pdf"},{"key":"10.1002\/pds.3678-BIB0005|pds3678-cit-0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006103.pub6","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"4","author":"Cahill","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/pds.3678-BIB0006|pds3678-cit-0006","unstructured":"FDA Drug Safety Communication Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease 2011 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm259161.htm"},{"key":"10.1002\/pds.3678-BIB0007|pds3678-cit-0007","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.110218","article-title":"Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis","author":"Singh","year":"2011","journal-title":"CMAJ"},{"key":"10.1002\/pds.3678-BIB0008|pds3678-cit-0008","doi-asserted-by":"crossref","first-page":"e2856","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis","volume":"344","author":"Prochaska","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/pds.3678-BIB0009|pds3678-cit-0009","unstructured":"FDA Drug Safety Communication Safety review update of Chantix (varenicline) and risk of cardiovascular adverse events 2012 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm330367.htm"},{"key":"10.1002\/pds.3678-BIB0010|pds3678-cit-0010","doi-asserted-by":"crossref","first-page":"e7176","DOI":"10.1136\/bmj.e7176","article-title":"Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study","author":"Svanstr\u00f6m","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/pds.3678-BIB0011|pds3678-cit-0011","first-page":"1226","article-title":"Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1002\/pds.3678-BIB0012|pds3678-cit-0012","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.290.1.86","article-title":"Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review","volume":"290","author":"Critchley","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/pds.3678-BIB0013|pds3678-cit-0013","unstructured":"Centers for Medicare and Medicaid Services Medicare program general information http:\/\/www.cms.hhs.gov\/MedicareGenInfo\/"},{"key":"10.1002\/pds.3678-BIB0014|pds3678-cit-0014","unstructured":"Centers for Medicare and Medicaid Services Prescription drug coverage-general information http:\/\/www.cms.hhs.gov\/PrescriptionDrugCovGenIn\/"},{"key":"10.1002\/pds.3678-BIB0015|pds3678-cit-0015","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"7497","key":"10.1002\/pds.3678-BIB0016|pds3678-cit-0016","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/bmj.330.7497.960","article-title":"Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding","volume":"330","author":"Mamdani","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/pds.3678-BIB0017|pds3678-cit-0017","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1002\/pds.3678-BIB0018|pds3678-cit-0018","first-page":"516","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"79","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1002\/pds.3678-BIB0019|pds3678-cit-0019","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","article-title":"Reducing bias in observational studies using subclassification on the propensity score","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J Am Stat Assoc"},{"key":"10.1002\/pds.3678-BIB0020|pds3678-cit-0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1214\/ss\/1009211805","article-title":"Confounding and collapsibility in causal inference","volume":"14","author":"Greenland","year":"1999","journal-title":"Stat Sci"},{"key":"10.1002\/pds.3678-BIB0021|pds3678-cit-0021","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","article-title":"Marginal structural models as a tool for standardization","volume":"14","author":"Sato","year":"2003","journal-title":"Epidemiology"},{"issue":"1","key":"10.1002\/pds.3678-BIB0022|pds3678-cit-0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"issue":"9","key":"10.1002\/pds.3678-BIB0023|pds3678-cit-0023","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1525-1497.1999.10198.x","article-title":"Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database","volume":"14","author":"Petersen","year":"1999","journal-title":"J Gen Intern Med"},{"issue":"11","key":"10.1002\/pds.3678-BIB0024|pds3678-cit-0024","first-page":"1277","article-title":"Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction","volume":"15","author":"Levy","year":"1999","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1002\/pds.3678-BIB0025|pds3678-cit-0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1067\/mhj.2002.123839","article-title":"A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario","volume":"144","author":"Austin","year":"2002","journal-title":"Am Heart J"},{"issue":"1","key":"10.1002\/pds.3678-BIB0026|pds3678-cit-0026","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Kiyota","year":"2004","journal-title":"Am Heart J"},{"issue":"11","key":"10.1002\/pds.3678-BIB0027|pds3678-cit-0027","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/pds.1821","article-title":"An algorithm to identify incident myocardial infarction using Medicaid data","volume":"18","author":"Choma","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1002\/pds.3678-BIB0028|pds3678-cit-0028","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1161\/01.STR.0000032240.28636.BD","article-title":"Validating administrative data in stroke research","volume":"33","author":"Tirschwell","year":"2002","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/pds.3678-BIB0029|pds3678-cit-0029","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pds.1518","article-title":"Validation of ICD-9 codes with a high positive predictive value for incident stroke resulting in hospitalization using Medicaid health data","volume":"17","author":"Roumie","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1002\/pds.3678-BIB0030|pds3678-cit-0030","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000174293.17959.a1","article-title":"Coding of stroke and stroke risk factors using International Classification of Diseases, revision 9 and 10","volume":"36","author":"Kokotaila","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/pds.3678-BIB0031|pds3678-cit-0031","first-page":"45","article-title":"The Social Security Administration's Death Master File: the completeness of death reporting at older ages","volume":"64","author":"Hill","year":"2001\/2002","journal-title":"Soc Secur Bull"},{"key":"10.1002\/pds.3678-BIB0032|pds3678-cit-0032","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pds.1619","article-title":"Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital Automated Database","volume":"17","author":"Varas-Lorenzo","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.3678-BIB0033|pds3678-cit-0033","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.2011.551","article-title":"Coronary revascularization trends in the United States, 2001-2008","volume":"305","author":"Epstein","year":"2011","journal-title":"JAMA"},{"key":"10.1002\/pds.3678-BIB0034|pds3678-cit-0034","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/archinte.160.12.1761","article-title":"Association between depression and mortality in older adults. The Cardiovascular Health Study","volume":"160","author":"Schulz","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1002\/pds.3678-BIB0035|pds3678-cit-0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.psy.0000181274.56785.28","article-title":"Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study","volume":"67","author":"Wulsin","year":"2005","journal-title":"Psychosom Med"},{"key":"10.1002\/pds.3678-BIB0036|pds3678-cit-0036","doi-asserted-by":"crossref","first-page":"494","DOI":"10.7326\/0003-4819-137-6-200209170-00009","article-title":"Smoking status and risk for recurrent coronary events after myocardial infarction","volume":"137","author":"Rea","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1002\/pds.3678-BIB0037|pds3678-cit-0037","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(06)69249-0","article-title":"Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study","volume":"368","author":"Teo","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/pds.3678-BIB0038|pds3678-cit-0038","unstructured":"Product labeling fro Zyban (bupropion) tablets http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020711s036lbl.pdf"},{"key":"10.1002\/pds.3678-BIB0039|pds3678-cit-0039","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/pds.2003","article-title":"Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand","volume":"19","author":"Harrison-Woolrych","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3678","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.3678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:49:08Z","timestamp":1625356148000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3678"}},"subtitle":["RISKS ASSOCIATED WITH VARENICLINE"],"short-title":[],"issued":{"date-parts":[[2014,7,5]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3678","relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7,5]]}}}